- Global Pharma News & Resources

Worldwide Closed System Transfer Devices Industry to 2026 - Growing Numbers of Oncology Treatment Centres Along With Hospitals for Cancer Treatments Presents Opportunities -

DUBLIN--(BUSINESS WIRE)--The "Closed System Transfer Devices Market Research Report by Type, by Closing Mechanism, by Component, by Technology, by End-Use, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Closed System Transfer Devices Market size was estimated at USD 712.69 million in 2020 and expected to reach USD 799.49 million in 2021, at a CAGR of 12.51% to reach USD 1,446.24 million by 2026.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Closed System Transfer Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Closed System Transfer Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Closed System Transfer Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Closed System Transfer Devices Market?

4. What is the competitive strategic window for opportunities in the Global Closed System Transfer Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Closed System Transfer Devices Market?

6. What is the market share of the leading vendors in the Global Closed System Transfer Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Closed System Transfer Devices Market?

Market Dynamics


  • Potential demand attributed to rising chronic diseased patients across the globe
  • Proliferation in utilization of cytotoxic and harmful drugs for treatment of numerous diseases
  • Emergence of advancement in closed system transfer devices


  • High cost associated with closed system transfer devices manufacturing


  • Ongoing investments with governmental fundings to assist usage of closed system transfer devices
  • Increasing government approvals of cancer treatments with closed system transfer devices
  • Growing numbers of oncology treatment centres along with hospitals for cancer treatments


  • Lack of governmental standards coupled with less awareness among the hospital professionals

Companies Mentioned

  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Caragen Limited
  • Cardinal Health, Inc.
  • Carmel Pharma AB
  • CODAN Medizinische Gerate GmbH & Co. KG
  • Corvida Medical
  • Epic Medical
  • Equashield LLC
  • ICU Medical Inc.
  • JMS North America Corporation
  • Medline Industries LP
  • Pfizer Inc.
  • REM Systems
  • Simplivia Healthcare
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Vygon SA
  • Yukon Medical, LLC

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 06-Jan-2022